Results 291 to 300 of about 6,406,057 (346)

Dual single‑nucleotide polymorphism biomarker combination for opioid selection to treat cancer pain. [PDF]

Mol Clin Oncol
Fujita Y, Matsuoka H, Chiba Y, Tsurutani J, Yoshida T, Sakai K, Nakura M, Sakamoto R, Makimura C, Ohtake Y, Tanaka K, Hayashi H, Takahama T, Tanizaki J, Koyama A, Nishio K, Nakagawa K.   +16 more
europepmc   +1 more source

Multiple low dose streptozotocin‐induced diabetes as a model for studying autoimmune diabetes in humans

Animal Models and Experimental Medicine, EarlyView.
Multiple low dose streptozotocin‐induced diabetes is a valuable animal model of diabetes type 1. It should be improved by further research on autoantigens, microbiota and mucosal immune cells from the gut, but also from other organs. Abstract The autoimmune response directed against pancreatic β cells is the most essential pathogenic process in type 1 ...
Ivan Koprivica, Suzana Stanisavljević, Dragica Mićanović, Ivana Stojanović, Đorđe Miljković   +4 more
wiley   +1 more source

Exploring opioid management challenges in chronic non-cancer pain: findings from a mixed-methods study among general practitioners in Germany. [PDF]

Fam Pract
Brinkmöller S, Poß-Doering R, Balzer A, Paul C, Wurmbach VS, Zugaj MR, Wensing M, Straßner C.   +7 more
europepmc   +1 more source

Analgesic treatment of refractory cancer pain caused by bone and soft tissue metastasis of lower esophageal and cardial adenocarcinoma: A case report. [PDF]

Medicine (Baltimore)
Tang J, Ding F, Yu M, Cai X.
europepmc   +1 more source

Erector spinae plane block for cancer pain relief: a systematic review. [PDF]

J Anesth Analg Crit Care
Capuano P, Alongi A, Burgio G, Martucci G, Arcadipane A, Cortegiani A.   +5 more
europepmc   +1 more source

Serum bone metabolism biomarkers in predicting tumor bone metastasis risk and their association with cancer pain: a retrospective study. [PDF]

Front Pain Res (Lausanne)
Zhang S, Huang K, Zhou T, Wang Y, Xu Y, Tang Q, Xiao G.   +6 more
europepmc   +1 more source

Conditioned open-label placebos to facilitate opioid reduction in patients with chronic non-cancer pain: study protocol of a randomised controlled trial. [PDF]

BMJ Open
Carratta K, Bodonyi K, Frey Nascimento A, Friis D, von Känel R, Bircher L, Koechlin H, Bernstein M, Streitberger K, Arnet I, Roth AJ, Ronel J, Olliges E, Locher C.   +13 more
europepmc   +1 more source

Naloxegol for the Treatment of Opioid-Induced Constipation in Patients with Cancer Pain: A Pooled Analysis of Real-World Data. [PDF]

Cancers (Basel)
Sabaté JM, Beato-Zambrano C, Cobo M, Lemaire A, Montesarchio V, Serna-Montros J, Namane R, Martín Baccarelli S, Rico-Villademoros F.   +8 more
europepmc   +1 more source